Latest Articlesddd
Regeneron in the NEWS Regeneron Pharmaceuticals (REGN) announced today that the investigational gene therapy DB-OTO improved …
Crispr Therapeutics in the NEWS CRISPR Therapeutics (CRSP) announced new preclinical data presented at the 27th …
Vertex Pharmaceuticals Vertex Pharmaceuticals (VRTX) reported consolidated financial 2024 results for the first quarter ended March …
CytomX Therapeutics CytomX Therapeutics, Inc. (CTMX) announced that it will report first quarter 2024 results and …
TG Therapeutics Financial Results for Q1 2024 TG Therapeutics, Inc. (TGTX) announced its financial results for …
From Akero Therapeutics Andrew Cheng, M.D., Ph.D., president and chief executive officer of Akero Therapeutics remarked, …
INmune Bio Press Release INmune Bio (NASDAQ: INMB) is pleased to share an update on two …
Pfizer Approval A one-time dose of the Pfizer product, BEQVEZ, has reduced bleeds post-treatment compared to …
Vertex Pharmaceuticals and TreeFrog Therapeutics in the NEWS Vertex Pharmaceuticals (VRTX) and TreeFrog Therapeutics announced that …
Regeneron Pharmaceuticals and Mammoth Biosciences in the NEWS Regeneron Pharmaceuticals (REGN) and Mammoth Biosciences, Inc. announced a …
Immunity Bio in the NEWS Immunity Bio (IBRX) - an immunotherapy company, announced that the U.S. …
Cerevel Therapeutics in the NEWS Cerevel Therapeutics (CERE) announced positive topline results from its pivotal Phase …
Vertex Pharmaceuticals in the NEWS Vertex Pharmaceuticals (VRTX) announced advancements across its suzetrigine pain program, which …
Voyager Therapeutics Voyager Therapeutics (VYGR) is a biotech company dedicated to leveraging the power of human …
Vertex Pharmaceuticals Acquisition of Alpine Immune Sciences We start this posting by answering a question by …
Syndax Pharmaceuticals in the NEWS Yesterday, Syndax Pharmaceuticals (NASDAQ: SNDX) announced the presentation of positive data …
Madrigal Pharmaceuticals in the NEWS Today, April 09, 2024, Madrigal Pharmaceuticals (MDGL) announced that its NASH …
Johnson & Johnson in the NEWS Today, Apr. 5, 2024 - Johnson & Johnson (JNJ) and …
BioStem Technologies Inc From Jason Matuszewski, CEO of BioStem Technologies (BSEM), who stated, “BioStem had an …
BioStem Technologies to Release Fourth Quarter Results BioStem Technologies (BSEM) is hosting a conference call and …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
